21-46125455-A-AC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001849.4(COL6A2):c.1817-3dup variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,609,932 control chromosomes in the GnomAD database, including 16,150 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1289 hom., cov: 30)
Exomes 𝑓: 0.13 ( 14861 hom. )
Consequence
COL6A2
NM_001849.4 splice_polypyrimidine_tract, intron
NM_001849.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.481
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 21-46125455-A-AC is Benign according to our data. Variant chr21-46125455-A-AC is described in ClinVar as [Benign]. Clinvar id is 93925.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.335 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | ENST00000300527.9 | NP_001840.3 | |||
COL6A2 | NM_058174.3 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | ENST00000397763.6 | NP_478054.2 | |||
COL6A2 | NM_058175.3 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001849.4 | ENSP00000300527 | P1 | |||
COL6A2 | ENST00000397763.6 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_058174.3 | ENSP00000380870 | ||||
COL6A2 | ENST00000413758.1 | c.485dup | p.Asp163ArgfsTer3 | frameshift_variant | 10/11 | 3 | ENSP00000395751 | |||
COL6A2 | ENST00000409416.6 | c.1817-3dup | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000387115 |
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18039AN: 151672Hom.: 1289 Cov.: 30
GnomAD3 genomes
AF:
AC:
18039
AN:
151672
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.130 AC: 32417AN: 249506Hom.: 2634 AF XY: 0.128 AC XY: 17355AN XY: 135402
GnomAD3 exomes
AF:
AC:
32417
AN:
249506
Hom.:
AF XY:
AC XY:
17355
AN XY:
135402
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.133 AC: 193389AN: 1458142Hom.: 14861 Cov.: 52 AF XY: 0.131 AC XY: 95357AN XY: 725414
GnomAD4 exome
AF:
AC:
193389
AN:
1458142
Hom.:
Cov.:
52
AF XY:
AC XY:
95357
AN XY:
725414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.119 AC: 18046AN: 151790Hom.: 1289 Cov.: 30 AF XY: 0.118 AC XY: 8765AN XY: 74192
GnomAD4 genome
AF:
AC:
18046
AN:
151790
Hom.:
Cov.:
30
AF XY:
AC XY:
8765
AN XY:
74192
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: High allele frequency. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 19, 2012 | - - |
Bethlem myopathy 1A Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Myosclerosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 11, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at